Inoperable chronic thromboembolic pulmonary hypertension: Evolution of prognosis over 10 years of new emerging therapies

DSpace/Manakin Repository

Inoperable chronic thromboembolic pulmonary hypertension: Evolution of prognosis over 10 years of new emerging therapies
 
Staal, Diederik P; Hendriks, Paul M; van Thor, Mitch C J; van de Groep, Liza D; van den Toorn, Leon M; Mulder, Berend-Jan M; Chandoesing, Prewesh P; Kauling, Robert M; Boerman, Sanne; van den Bosch, Annemien E; Mager, Johannes J; Boomars, Karin A; Post, Martijn C
(2024) Pulmonary Circulation, volume 14, issue 3
(Article)
Abstract
Therapies for inoperable chronic thromboembolic pulmonary hypertension (CTEPH) include balloon pulmonary angioplasty (BPA) and PH-specific medical therapy. This study compares survival and its predictors before and after the introduction of BPA. BPA was independently associated with survival; however, there was no difference in overall survival between the two cohorts.
Download/Full Text
Open Access version via Utrecht University Repository Publisher version
Version on publisher website for UU-students and staff
Version on publisher website
 
Keywords: chronic thromboembolic pulmonary hypertension, prognosis, pulmonary embolism, pulmonary hypertension, survival, Journal Article
DOI: https://doi.org/10.1002/pul2.12419
ISSN: 2045-8932
Publisher: SAGE Publications Inc.
Note: © 2024 The Author(s). Pulmonary Circulation published by Wiley Periodicals LLC on behalf of the Pulmonary Vascular Research Institute.
(Peer reviewed)